Although noted without comment in a previous genome-wide assessment of CNVs in 1073 cases of schizophrenia and 1148 controls, two patients were identified with duplications in SRGAP3, and none of the controls had CNVs in this region although this did not reach significance and no family data was collected [10]. Here, SRGAP3 is linked to schizophrenia.